DNA Test Kit Market Size, Share, and Industry Analysis, By Application (Ancestry Testing, Personal Traits, Disease Risk Assessment, Fitness & Wellness Test, and Others), By Sample Type (Saliva, Cheek Swab, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Others), and Regional Forecast, 2025-2032

DNA tests involve the analysis of a person’s genetic material to gather information about their genetic makeup. The DNA test kits are one of the most prominent at-home self-testing kits used to get insights into an individual’s health, ancestry, and identity. The samples are collected using simple and non-invasive methods such as cheek swabs, saliva, or urine samples.

DNA test kits are used for various areas, such as ancestry testing, health and wellness, disease risk assessment, and prenatal testing. DNA test enables the tailoring of personalized medicine based on an individual’s genetic makeup to identify the genetic risks for particular diseases so that early intervention and lifestyle adjustments can be done. It contributes to the scientific research and understanding of family heritage with the help of genetic and human biology.

Furthermore, the rising prevalence of chronic diseases such as cancer, cardiac diseases, neurodegenerative diseases, and genetic diseases leads to the increasing demand for prior DNA tests to take prior intervention and lifestyle modification to reduce the risk of life. Thus propelling the growth of the DNA test kit market.

• For instance, according to the data published by Breastcancer.org, an estimated 297,790 new cases were registered for breast cancer in the U.S. in 2023. Also, approximately one in eight women in the U.S. are going to develop breast cancer in the course of their life. Such cases are expected to propel the product demand in the market.

Moreover, the rising awareness among people regarding personalized treatment options and the increasing focus of pharmaceutical and biotechnological companies to launch personalized medicine with the help of the genetic database is expected to boost the DNA test kit market during the forecast period.

• For instance, in October 2023, 23andMe, Inc. collaborated with GSK and entered into a nonexclusive data licensing agreement for utilizing the 23andMe database to use it in novel drug target discovery and research. Such collaborations boost the growth of the DNA test kit market.

The COVID-19 pandemic positively impacted the DNA test kit market. With the increasing number of COVID-19 cases and the rising risk of getting infected with the deadly virus, the growth in sales of at-home DNA testing was observed. Furthermore, the market stabilized during 2021, with a decrease in COVID-19 cases. However, the market has maintained its pre-pandemic position with an increased demand for the identification of disease traits, maintaining health and wellness, and identifying ancestry in 2023. These factors are expected to boost the growth of the DNA test kit market during the forecast period.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Key Diseases, By Key Countries/Regions, 2023
• Regulatory & Reimbursement Scenario for Genetic Testing
• Key Industry Developments - Mergers, Acquisitions, Partnerships, and Launches
• Impact of COVID-19 on the Market

Analysis by Application

Based on application, the DNA test kit market is segmented into ancestry testing, personal traits, disease risk assessment, fitness & wellness test, and others.

The disease risk assessment segment held a considerable share of the market in 2023. The dominant position in the market is augmented by the increasing prevalence of chronic and genetic diseases, the rise in the awareness of genetic health risks, the emergence of preventive healthcare, and the increased demand for DNA test kits for disease risk assessment. Also, the personalized medicine approach tailors the treatment options according to the individual’s genetic makeup, thus propelling the adoption of the test kits and boosting the growth of the segment in the market.

Moreover, the increasing number of new service options for disease risk assessment by key players has increased the demand for DNA test kits for disease risk assessments.

• For instance, in November 2023, 23andMe Holding Co. launched the 23andMe+ Total Health, a new membership option that offers clinical grade exome sequencing, biannual blood testing, and access to genetics-based clinical care. This membership is designed for individuals looking to enhance their healthcare experience with comprehensive genetic testing, blood biomarker testing, risk assessment in key health areas, and personalized health plans developed by genetics-trained clinicians, providing a holistic approach to preventive health and genetic understanding. Such expansion of the plans by the key players thus led to the extensive adoption of the kits during the forecast period.

The ancestry testing segment also held a considerable share of the global market as an increasing number of individuals in key countries, such as the U.S., are adopting these tests.

• According to research published by the MIT Technology Review in February 2019, more than 26 million individuals had undertaken an at-home ancestry test.

Regional Analysis

To gain extensive insights into the market, Download for Customization

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the global DNA test kit market in 2023. The region's increasing prevalence of chronic diseases, such as cancers and cardiac diseases, and the rising risk of genetic disorders have boosted the demand for DNA testing for the analysis of any deformities in the gene and managing the conditions as early as possible. Such awareness among the people of the region has propelled market growth. Additionally, an increase in product launches by key players to understand the potential risk associated with any disease with the help of genetic testing has boosted the market growth in the region.

• For instance, in July 2023, Quest Diagnostics launched a consumer-initiated genetic test to help people understand their potential risk of developing certain inheritable health conditions and offer end-to-end support with personalized reports and counseling.

Furthermore, the increasing presence of stringent regulatory policies for the easy availability of technologically superior DNA test kits, along with the presence of advanced healthcare infrastructure and research and development facilities in the region, has boosted the market growth in the region.

Additionally, Europe held a notable portion of the global DNA test kit market in 2023. Owing to the increasing number of genetic disorders in the region and the rising demand for early intervention for chronic diseases to increase life expectancy, the demand for DNA test kits in the region has been boosted.

• For instance, in February 2023, according to the data published by the European Commission (EU), around 36.0 million people in the European Union (EU) are living with rare diseases, and 80% of diseases are genetically originated. Such a large number of cases has increased the awareness among the people of the region to check their genetic makeup.

Also, the presence of key players and new product and service launches promotes market growth in the region.

Key Players Covered

The report includes the profiles of key players, such as 23andMe, Inc., tellmeGen, Ancestry, Sano Genetics, MyHeritage Ltd., Living DNA Ltd, Gene by Gene, Ltd. (Family Tree DNA), Nebula Genomics, and SelfDecode.

Key Industry Developments

• In April 2024, Nucleus Genomics collaborated with Illumina to introduce a direct-to-consumer (DTC) whole-genome sequencing (WGS) test offering a fee of USD 399 and a USD 39 annual fee.
• In November 2023, Kintree collaborated with Mapmygenome to provide DNA test kits for users to trace their ancestry or ethnicity and make it accessible to every individual curious about their ancestry.
• In March 2023, Reliance Industries announced the launch of a DNA testing kit worth USD 145.3 in India. This test kit is used to reveal inherited genetic disorders and chronic diseases such as cancer, cardiac disorders, and neurodegenerative diseases.